Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Gland Pharma Ltd. ( (IN:GLAND) ) is now available.
Gland Pharma Limited has notified the stock exchanges that it conducted its earnings call for the quarter and nine months ended 31 December 2025 on 28 January 2026 and has made the audio recording of the call available on its website. The disclosure, made under SEBI’s listing and disclosure regulations, enhances transparency for investors and analysts by providing direct access to management’s commentary on financial performance and outlook, reinforcing the company’s compliance and communication practices with capital-market stakeholders.
More about Gland Pharma Ltd.
Gland Pharma Limited is an India-based pharmaceutical company focused on the development, manufacturing and marketing of injectable formulations. It supplies sterile injectables to regulated and semi-regulated markets worldwide, serving both hospital and institutional segments with a portfolio spanning critical care, anti-infectives and other specialty therapies.
Average Trading Volume: 13,913
Technical Sentiment Signal: Sell
Current Market Cap: 277.1B INR
For a thorough assessment of GLAND stock, go to TipRanks’ Stock Analysis page.